|
|
||||||||
|
FJ
EXPRESS SUMMARY ARTICLE The Full-length version of this article is also available, published online November 1, 2004 as doi:10.1096/fj.04-1942fje. |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




* INSERM U410, Faculté de Médecine Bichat, Paris, France;
Department for Molecular Biomedical Research, VIB-Ghent University, Ghent; and
Laboratory of Experimental Cancerology, Ghent University Hospital, Ghent, Belgium
1Correspondence: INSERM U410, Faculté de Médecine X. Bichat, 16 rue Huchard, Paris 74018, France. E-mail: chastre{at}bichat.inserm.fr
SPECIFIC AIMS
We reported the critical role of lipid phosphatase activity of the PTEN tumor suppressor in stabilizing the E-cadherin junctional complexes and reverting invasiveness. Here we investigate the molecular partners and signaling pathways of E-cadherin junctional complexes and PTEN relative to the invasive phenotype to identify the molecular mechanisms involved.
PRINCIPAL FINDINGS
1. Interaction of PTEN and PI3K with E-cadherin/catenin complexes
We conducted coimmunoprecipitation studies with the kidney epithelial HEK 293 and MDCK cells transiently transfected with PTEN expression vectors. PTEN was identified in E-cadherin, ß-catenin (ß-ctn), and p120ctn immunocomplexes. ß-Catenin and p120ctn were identified in PTEN immunoprecipitates. The p85 regulatory subunit of PI3K coimmunoprecipitated with E-cadherin and catenins.
2. Implication of the MAGI-1b scaffolding molecule in the recruitment of PTEN to junctional complexes
To investigate whether PTEN binds directly to E-cadherin or catenins, we performed a yeast two-hybrid (Y2H) assay; no interaction of PTEN with E-cadherin, ß-ctn,
E-catenin, or p120ctn was observed (Fig. 1
A), suggesting the involvement of adaptor proteins. We addressed this by analyzing the possible interaction with MAGI-1b, a scaffold molecule involved in the formation of specialized cell-cell junctions. The Y2H assay demonstrated that PTEN interacts indirectly with ß-ctn through MAGI-1b. We showed that PTEN binds selectively the 2nd PDZ domain of MAGI-1b whereas ß-ctn binds the 5th PDZ domain (Fig. 1A
). The association of MAGI-1b with PTEN and ß-ctn was corroborated by coimmunoprecipitation in kidney epithelial HEK 293 and MDCK cell lines and in MDCKts-src cells, MDCK derivatives transformed by a temperature-sensitive v-src (Fig. 1B-D
). The interaction of PTEN with E-cadherin junctional complexes involved the PDZ binding motifs of PTEN and ß-ctn, as evidenced by the inability of C-terminally truncated PTENStop399 to interact with MAGI-1b (Fig. 1B
) and by disruption of the PTEN/ß-ctn-E-cadherin complex after intracellular transfer of a peptide corresponding to the C terminus of ß-ctn and competing with ß-ctn for binding to MAGI-1b.
|
Colocalization of MAGI-1b with E-cadherin was further confirmed immunohistochemically (Fig. 1E
). In the human colonic adenocarcinoma HT-29 and Caco-2 cell lines, which express higher amounts of PTEN than MDCK cells, we noted the interaction of endogenous PTEN with MAGI-1b and identified MAGI-1b in E-cadherin junctional complexes. In Caco-2 cells, we confirmed by confocal microscopy that MAGI-1b and PTEN were colocalized with ß-ctn/E-cadherin adhesion complexes at cell-cell contacts. These studies demonstrate that MAGI-1b localizes to the plasma membrane and assembles signaling complexes involving E-cadherin, ß-ctn, and PTEN under physiological conditions.
3. Invasion suppressor activity of MAGI-1b/PTEN complexes
Invasion assays in type-I collagen gels using the MDCKts-src derivatives confirmed that overexpression of wild-type MAGI-1b or MAGI-1b domains PDZ245 results in near complete reversion of Src-induced invasiveness, implicating this adaptor molecule in the control of cell invasiveness (Fig. 2
A). Individual 2nd and 5th PDZ domains of MAGI-1b did not cause reversion. The suppressive effects of MAGI-1b on the Src-induced invasiveness required its interaction with ß-ctn, since it was reverted by the C-terminal ß-ctn competing peptide but not by a ß-ctn control peptide (Fig. 2A
). In PTEN-deficient human prostate PC-3 carcinoma cells, ectopic expression of MAGI-1b did not suppress invasiveness. The invasive phenotype of PC-3 cells depends on the PI3K pathways, as it is blocked by the specific PI3K antagonist LY294002 and by restoration of wild-type PTEN expression. These results suggest that recruitment of PTEN to junctional complexes through its interaction with ß-ctn via MAGI-1b plays a critical role in the control of PI3K effector systems and the invasive phenotype.
|
Because MAGI-1b interfered with cell invasiveness, we investigated by a fast aggregation assay whether MAGI-1b affects the E-cadherin-dependent adhesion. Parental MDCKts-src cells are characterized by an inability to aggregate at the temperature permissive for Src activity (35°C), though they form aggregates at 40°C in an E-cadherin-dependent manner as demonstrated by inhibition with the E-cadherin neutralizing antibody DECMA-1 (Fig. 2B
). In contrast, cells transfected with wild-type MAGI-1b, PDZ245 or PDZ2345 domains, but not with the individual 2nd or 5th PDZ domains, formed aggregates at the temperature permissive for Src activity.
4. Requirement of AKT kinase activity in Src-induced invasiveness
We show that ectopic expression of MAGI-1b in MDCKts-src derivatives decreases the activity of AKT, a downstream effector of PI3K and demonstrate that stable transfection of constitutively active (myristilated), but not wild-type AKT, induces invasiveness of MDCKts-src at a temperature restricting Src activity. These effects were not associated with notable changes in the accumulation of E-cadherin or ß-ctn. Conversely, dominant negative AKT reverted Src-induced invasiveness. Thus, AKT activity is required and sufficient to trigger invasiveness of MDCKts-src cells. To address a putative effect of MAGI-1b on AKT activity independent of PTEN, we performed complementary experiments in the human PTEN-defective PC-3 cells. Ectopic expression of MAGI-1b in PC-3 cell derivatives did not affect AKT activity. AKT activity was decreased by transient transfection of wild-type PTEN, and this effect was potentiated by cotransfection of MAGI-1b, indicating that PTEN is required for the MAGI-1b-induced down-regulation of AKT activity.
Taken together, our data indicate that Src-induced migration requires AKT activity, whereas the destabilization of junctional complexes involved both AKT-dependent and AKT-independent pathways.
CONCLUSIONS AND SIGNIFICANCE
Cadherin junctional complexes are critical to the control of many cellular functions, including cell survival, proliferation, and differentiation. Disruption of these junctional complexes hallmarks neoplastic progression and is associated with invasiveness and metastasis.
Our results demonstrate that E-cadherin and catenins are components of large signaling complexes involving PI3K and the MAGI-1b/PTEN signalosome. It is becoming clearer that scaffold molecules play a critical role in organizing signaling complexes that control cell growth, differentiation, and function. An emerging group of proteins with PDZ domains (e.g., MAGI-1b) triggers the assembly and subcellular localization of multiprotein complexes, generally at the membrane-cytoplasm interface. Our study extends this to cell adhesion molecules and demonstrates that MAGI-1b plays a critical role in maintaining cell-cell contacts and reversing invasiveness. According to this signalosome model (Fig. 3
), we propose that PTEN is recruited to specific subcellular microenvironments (e.g., adherens junctions) via binding of its PDZ binding motif to scaffolding molecules such as MAGI-1b, which in turn bind to the cadherin/catenin complex via ß-ctn. As ß-ctn also binds the PI3K enzyme, adherens junctions function as focal points to regulate PIP3 pools and control recruitment and activation of downstream effector systems. Our results demonstrate that Src-induced invasiveness involves both AKT-dependent and -independent pathways. A future challenge is to elucidate the spatiotemporal regulation of these macromolecular complexes.
|
FOOTNOTES
To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.04-1942fje;
This article has been cited by other articles:
![]() |
S. S. Barbieri, L. Ruggiero, E. Tremoli, and B. B. Weksler Suppressing PTEN Activity by Tobacco Smoke Plus Interleukin-1{beta} Modulates Dissociation of VE-Cadherin/{beta}-Catenin Complexes in Endothelium Arterioscler. Thromb. Vasc. Biol., April 1, 2008; 28(4): 732 - 738. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Barber, M. Alvarado-Kristensson, A. Gonzalez-Garcia, R. Pulido, and A. C. Carrera PTEN Regulation, a Novel Function for the p85 Subunit of Phosphoinositide 3-Kinase Sci. Signal., November 21, 2006; 2006(362): pe49 - pe49. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Taniguchi, T. T. Tran, T. Kondo, J. Luo, K. Ueki, L. C. Cantley, and C. R. Kahn Phosphoinositide 3-kinase regulatory subunit p85{alpha} suppresses insulin action via positive regulation of PTEN PNAS, August 8, 2006; 103(32): 12093 - 12097. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sakurai, S. Fukuhara, A. Yamagishi, K. Sako, Y. Kamioka, M. Masuda, Y. Nakaoka, and N. Mochizuki MAGI-1 Is Required for Rap1 Activation upon Cell-Cell Contact and for Enhancement of Vascular Endothelial Cadherin-mediated Cell Adhesion Mol. Biol. Cell, February 1, 2006; 17(2): 966 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. T. Chartier, M. Laine, S. Gout, G. Pawlak, C. A. Marie, P. Matos, M. R. Block, and M. R. Jacquier-Sarlin Laminin-5-integrin interaction signals through PI 3-kinase and Rac1b to promote assembly of adherens junctions in HT-29 cells J. Cell Sci., January 1, 2006; 119(1): 31 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Valiente, A. Andres-Pons, B. Gomar, J. Torres, A. Gil, C. Tapparel, S. E. Antonarakis, and R. Pulido Binding of PTEN to Specific PDZ Domains Contributes to PTEN Protein Stability and Phosphorylation by Microtubule-associated Serine/Threonine Kinases J. Biol. Chem., August 12, 2005; 280(32): 28936 - 28943. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. von Stein, A. Ramrath, A. Grimm, M. Muller-Borg, and A. Wodarz Direct association of Bazooka/PAR-3 with the lipid phosphatase PTEN reveals a link between the PAR/aPKC complex and phosphoinositide signaling Development, April 1, 2005; 132(7): 1675 - 1686. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |